Cargando…

Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264474/ https://www.ncbi.nlm.nih.gov/pubmed/27916137 http://dx.doi.org/10.1016/j.ebiom.2016.11.014

Ejemplares similares

Immunotherapy in renal cell cancer: the more the merrier?
por: Camarero, Jorge, et al.
Publicado: (2013)

The more IGRT systems, the merrier?
por: Sun, Baozhou, et al.
Publicado: (2017)

Fault-Detection Managers: More May Not Be the Merrier
por: Zamani, Ghazal, et al.
Publicado: (2021)

The More (Social Group Memberships), the Merrier: Is This the Case for Asians?
por: Chang, Melissa X.-L., et al.
Publicado: (2016)

The More the Merrier: Multiple Genomes in a Parasitic Prokaryote
por: Gross, Liza
Publicado: (2006)

Is More Always Merrier? Intersectionality as an Antecedent of Job Insecurity
por: Lavaysse, Lindsey M., et al.
Publicado: (2018)

The More the Merrier—Complexity in Long Non-Coding RNA Loci
por: Ziegler, Christian, et al.
Publicado: (2017)

Distributed practice. The more the merrier? A randomised bronchoscopy simulation study
por: Bjerrum, Anne Sofie, et al.
Publicado: (2016)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

The More the Merrier? Should Antibiotics be Used for Rhinoplasty and Septorhinoplasty?—A Review
por: Kullar, Ravina, et al.
Publicado: (2018)

Decision-making from temporally accumulated conflicting evidence: The more the merrier
por: Mocz, Viola, et al.
Publicado: (2023)

1198. More is not Merrier: Mitigating Meropenem Misuse in the ICU at an Academic Medical Center
por: Huang, Angela, et al.
Publicado: (2023)

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies
por: Arasanz, Hugo, et al.
Publicado: (2018)

Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
por: Zheng, Ming
Publicado: (2022)

ASO Author Reflections: Sentinel Lymph Node Biopsy Trend in Melanoma: The More the Merrier
por: El Sharouni, Mary-Ann, et al.
Publicado: (2019)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Hjorth, Stephan
Publicado: (2021)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
por: Martinez-Perez, Alejandra, et al.
Publicado: (2022)

The more the merrier? Increasing group size may be detrimental to decision-making performance in nominal groups
por: Amir, Ofra, et al.
Publicado: (2018)

The feminization of medicine in Latin America: ‘More-the-merrier’ will not beget gender equity or strengthen health systems
por: Knaul, Felicia Marie, et al.
Publicado: (2022)

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer
por: Riess, Jonathan W., et al.
Publicado: (2016)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

The more the merrier: Conspecific density improves performance of gregarious larvae and reduces susceptibility to a pupal parasitoid
por: Rosa, Elena, et al.
Publicado: (2017)

Pterional Approach for Anterior Skull Base Midline Meningiomas against “The More The Merrier” Approach: An Institutional Experience
por: Gowtham, Matham, et al.
Publicado: (2023)

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
por: Swart, Maarten, et al.
Publicado: (2016)

Immune checkpoint blockade therapy for bladder cancer treatment
por: Kim, Jayoung
Publicado: (2016)

LIGHTing tumor up for checkpoint blockade
por: Liang, Yong, et al.
Publicado: (2016)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Acquired Resistance to Immune Checkpoint Blockade Therapies
por: Zhao, Xianda, et al.
Publicado: (2020)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Microbial biomarkers for immune checkpoint blockade therapy against cancer
por: Adachi, Keishi, et al.
Publicado: (2018)

Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
por: Liu, Zefan, et al.
Publicado: (2022)

When more is not merrier: Using wild population dynamics to understand the effect of density on ex situ seahorse mating behaviors
por: Masonjones, Heather D., et al.
Publicado: (2019)

The More, the Merrier? Multiple Myoglobin Genes in Fish Species, Especially in Gray Bichir (Polypterus senegalus) and Reedfish (Erpetoichthys calabaricus)
por: Helfenrath, Kathrin, et al.
Publicado: (2021)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy
por: Cremolini, Chiara, et al.
Publicado: (2021)

Metabolic predictors of response to immune checkpoint blockade therapy
por: Shorer, Ofir, et al.
Publicado: (2023)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ijg69ajn0aj8ra0e7td23u2qri